8TH INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES

第八届国际传染病大会

基本信息

项目摘要

Support is request to permit 20 young US investigators in infectious diseases to attend the 8th International Congress for Infectious Disease (ICID) to be held in Boston from May 15-18 1998. The Congress brings together over 5,000 participants from 100 countries to discuss the spectrum of scientific and clinical advances in microbiology and infectious diseases. Besides allowing young US investigators to meet and to interact with internationally known investigators, the 8th ICID is unique among international infectious disease meetings in attracting broad participation from physicians and scientists from developing countries. Goals of Healthy People 2000 include the reduction of tuberculosis, human immunodeficiency virus, vaccine preventable diseases, and the prevention of the emergence of new infectious diseases, Achieving these goals increasingly requires international efforts and cooperation. Examples include studies to address the rising percentage of foreign-born US tuberculosis cases and international HIV vaccine trials. Furthermore, resource poor countries bear the brunt of morbidity and mortality from emerging and re-emerging infectious diseases. Investigations in these countries with local colleagues will be essential for US investigators to be involved in the understanding and control of these diseases. The early studies of HIV throughout Africa, the recent work on Ebola virus in Gabon by the Centers for Disease control and Prevention, and the ongoing collaborations involving US and South American investigators to understand the molecular epidemiology of antibiotic resistant Streptococcus pneumoniae are examples of the importance of these relationships. The 8th ICID will help young US investigators develop the contacts and relationships necessary for these international efforts. Symposia on clinical treatment updates, advances in traditional and molecular epidemiology, infection control practices, developments in immunology and molecular genetics and microbiology will be included. The program content is overseen by a committee of internationally known infectious disease physicians and scientists. Both the Committee and the Congress are the responsibility of the International Society for Infectious Diseases (ISID) The 8th ICID is being co-sponsored by the Infectious Diseases Society of America and the Channing laboratory, a division of the Brigham and Women's Hospital Department of Medicine and Harvard Medical School. Portions of the program are expected to be accredited for continuing medical education credits.
支持允许20名年轻的美国研究人员进行传染病研究的请求

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dennis L. Kasper其他文献

Publisher Correction: Host immunomodulatory lipids created by symbionts from dietary amino acids
出版商更正:由膳食氨基酸共生体产生的宿主免疫调节脂质
  • DOI:
    10.1038/s41586-021-04276-7
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    Sungwhan F. Oh;T. Praveena;Heebum Song;Ji;Da;Deniz Erturk‐Hasdemir;Yoon Soo Hwang;ChangWon C. Lee;Jérôme Le Nours;Hyunsoo Kim;Jesang Lee;R. Blumberg;J. Rossjohn;Seung Bum Park;Dennis L. Kasper
  • 通讯作者:
    Dennis L. Kasper
Targeting symbionts by apolipoprotein L proteins modulates gut immunity
靶向载脂蛋白 L 蛋白的共生体调节肠道免疫
  • DOI:
    10.1038/s41586-025-08990-4
  • 发表时间:
    2025-05-14
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Tao Yang;Xiaohu Hu;Fei Cao;Fenglin Yun;Kaiwen Jia;Mingxiang Zhang;Gaohui Kong;Biyu Nie;Yuexing Liu;Haohao Zhang;Xiaoyu Li;Hongyan Gao;Jiantao Shi;Guanxiang Liang;Guohong Hu;Dennis L. Kasper;Xinyang Song;Youcun Qian
  • 通讯作者:
    Youcun Qian
Complex human gut microbiome cultured in anaerobic human intestine chips
在厌氧人体肠道芯片中培养的复杂人体肠道微生物组
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sasan Jalili;F. Gazzaniga;E. Calamari;Diogo M. Camacho;Cicely Fadel;Bret A. Nestor;Michael J. Cronce;Alessio Tovaglieri;O. Levy;K. Gregory;D. Breault;J. Cabral;Dennis L. Kasper;R. Novák;D. Ingber
  • 通讯作者:
    D. Ingber
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.
B 族链球菌 III 型菌株感染中荚膜多糖抗体的定量测定。
  • DOI:
  • 发表时间:
    1977
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    Carol J. Baker;Dennis L. Kasper;Ira B. Tager;Abel Paredes;Susan Alpert;William M. McCormack;D. K. Goroff
  • 通讯作者:
    D. K. Goroff
Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis.
脆弱拟杆菌亚种脆弱脂多糖的化学和生物学特征。

Dennis L. Kasper的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dennis L. Kasper', 18)}}的其他基金

Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
阐明下一代糖复合疫苗的结构要求
  • 批准号:
    10321266
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
阐明下一代糖复合疫苗的结构要求
  • 批准号:
    10533764
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
阐明下一代糖复合疫苗的结构要求
  • 批准号:
    10084269
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
抗菌治疗和疫苗开发的创新平台
  • 批准号:
    8791872
  • 财政年份:
    2014
  • 资助金额:
    $ 0.5万
  • 项目类别:
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
抗菌治疗和疫苗开发的创新平台
  • 批准号:
    8641912
  • 财政年份:
    2014
  • 资助金额:
    $ 0.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8375442
  • 财政年份:
    2012
  • 资助金额:
    $ 0.5万
  • 项目类别:
Knowledge-based Vaccines Built on Paradigm Changes in Antigen Presentation
基于抗原呈现范式变化的知识疫苗
  • 批准号:
    8626352
  • 财政年份:
    2011
  • 资助金额:
    $ 0.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8233430
  • 财政年份:
    2011
  • 资助金额:
    $ 0.5万
  • 项目类别:
Development of a conjugate vaccine for the prevention of tularemia
开发预防兔热病的结合疫苗
  • 批准号:
    8233446
  • 财政年份:
    2011
  • 资助金额:
    $ 0.5万
  • 项目类别:
Knowledge-based Vaccines Built on Paradigm Changes in Antigen Presentation
基于抗原呈现范式变化的知识疫苗
  • 批准号:
    8434003
  • 财政年份:
    2011
  • 资助金额:
    $ 0.5万
  • 项目类别:

相似海外基金

Develop a programme to support the prevention of Non-Communicable Diseases (NCDs) in the Republic of Kenya.
制定一项计划,支持肯尼亚共和国预防非传染性疾病 (NCD)。
  • 批准号:
    23K09892
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research Training in Global Non-Communicable Diseases
全球非传染性疾病研究培训
  • 批准号:
    10554719
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
Non-Communicable Diseases
非传染性疾病
  • 批准号:
    MC_UU_00033/3
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Intramural
Usefulness of metabolite biomarker as a common pathway for the prevention of non-communicable diseases and frailty
代谢生物标志物作为预防非传染性疾病和虚弱的常见途径的有用性
  • 批准号:
    23H00452
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda
加强乌干达非传染性疾病创新全球卫生技术的研究能力
  • 批准号:
    10469877
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
Building capacity for Implementation Science research in Non-Communicable Diseases (BImS-NCDs)
非传染性疾病(BImS-NCD)实施科学研究的能力建设
  • 批准号:
    10469788
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
Building capacity for Implementation Science research in Non-Communicable Diseases (BImS-NCDs)
非传染性疾病(BImS-NCD)实施科学研究的能力建设
  • 批准号:
    10594552
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
Occupational disparities in survival from cancer and non-communicable diseases
癌症和非传染性疾病生存率的职业差异
  • 批准号:
    22K17401
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
"Increasing take-up of preventative health behaviours to mitigate the rise of non-communicable diseases in lower- and middle- income countries: a comp
“在低收入和中等收入国家中,更多地采用预防性健康行为来减缓非传染性疾病的增加:一项比较
  • 批准号:
    2751288
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Studentship
Development of a comprehensive self-care system utilizing big data/AI to cure non-communicable diseases and validation of its effectiveness
开发利用大数据/人工智能治疗非传染性疾病的综合自我护理系统并验证其有效性
  • 批准号:
    22H03529
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了